• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 5. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886

Market Research and Analysis of 2-Amino-5-Bromo-4-Bromomethyl-1H-Benzimidazole (CAS No. 1803892-06-9)

The compound 2-Amino-5-Bromo-4-Bromomethyl-1H-Benzimidazole, identified by the CAS number 1803892-06-9, has garnered significant attention in the chemical and pharmaceutical industries due to its unique structural properties and potential applications in drug development. This benzimidazole derivative is characterized by the presence of amino and bromine substituents, which confer it with distinct chemical reactivity and biological activity.

Recent studies have highlighted the role of this compound in various research areas, including its use as an intermediate in the synthesis of bioactive molecules. Its structure facilitates the formation of hydrogen bonds and π-interactions, making it a promising candidate for targeting specific biological pathways. The compound has been explored in preclinical models for its potential anti-inflammatory, antitumor, and antimicrobial activities.

The global market for specialty chemicals like 2-Amino-5-Bromo-4-Bromomethyl-1H-Benzimidazole is driven by increasing demand from the pharmaceutical and biotechnology sectors. Key players in the industry are focusing on optimizing synthesis routes to enhance yield and reduce production costs. Additionally, regulatory frameworks governing chemical safety and environmental impact are influencing market dynamics, with a growing emphasis on sustainable manufacturing practices.

From a supply chain perspective, several global suppliers specialize in the production of this compound, catering to both academic research institutions and commercial enterprises. The procurement demand is highest in regions with robust pharmaceutical R&D activities, such as North America, Europe, and Asia-Pacific. However, challenges such as raw material availability and intellectual property rights continue to impact market accessibility.

In conclusion, 2-Amino-5-Bromo-4-Bromomethyl-1H-Benzimidazole represents a valuable asset in the chemical toolbox for researchers and industry professionals alike. Its versatile applications and ongoing advancements in synthesis methodologies position it as a key player in future drug discovery efforts. As the market evolves, stakeholders are expected to prioritize innovation and sustainability to meet the growing demands of this dynamic field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)